BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,029 filers reported holding BAXTER INTL INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $601,000 | -29.1% | 7,478 | -29.0% | 0.02% | -33.3% |
| Q2 2021 | $848,000 | -38.9% | 10,536 | -35.9% | 0.03% | -44.1% |
| Q1 2021 | $1,387,000 | +0.4% | 16,442 | -4.5% | 0.06% | -3.3% |
| Q4 2020 | $1,381,000 | +1.1% | 17,208 | +1.3% | 0.06% | -3.2% |
| Q3 2020 | $1,366,000 | -8.0% | 16,988 | -1.5% | 0.06% | -18.2% |
| Q2 2020 | $1,485,000 | -5.7% | 17,250 | -11.0% | 0.08% | -19.8% |
| Q1 2020 | $1,574,000 | -36.5% | 19,388 | -34.5% | 0.10% | -22.0% |
| Q4 2019 | $2,477,000 | -4.4% | 29,621 | -0.0% | 0.12% | -10.9% |
| Q3 2019 | $2,592,000 | +5.3% | 29,635 | -1.4% | 0.14% | 0.0% |
| Q2 2019 | $2,462,000 | +22.5% | 30,063 | +21.6% | 0.14% | +16.0% |
| Q1 2019 | $2,010,000 | +40.3% | 24,722 | +13.6% | 0.12% | +32.2% |
| Q4 2018 | $1,433,000 | +268.4% | 21,766 | +331.9% | 0.09% | +309.1% |
| Q3 2018 | $389,000 | +27.1% | 5,040 | +21.7% | 0.02% | +22.2% |
| Q2 2018 | $306,000 | +13.8% | 4,140 | +0.1% | 0.02% | +20.0% |
| Q1 2018 | $269,000 | +14.0% | 4,137 | +13.4% | 0.02% | +15.4% |
| Q4 2017 | $236,000 | +3.1% | 3,648 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $229,000 | +9.6% | 3,648 | +5.8% | 0.01% | +8.3% |
| Q2 2017 | $209,000 | -22.0% | 3,448 | -10.2% | 0.01% | -42.9% |
| Q2 2015 | $268,000 | -0.7% | 3,839 | -2.4% | 0.02% | -8.7% |
| Q1 2015 | $270,000 | +13.4% | 3,935 | +21.0% | 0.02% | +9.5% |
| Q4 2014 | $238,000 | – | 3,253 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |